Patients with hypertension and the cardiometabolic syndrome: the potential impact of inflammatory biomarkers.
Morris
Alanna
A
Emory University School of Medicine, Atlanta, GA 30322, USA. aamorr3@emory.edu
Ferdinand
Keith C
KC
D001741:Black or African American / Q000208:ethnology; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000208:ethnology; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000150:complications / Q000208:ethnology; D007249:Inflammation / Q000097:blood* / Q000150:complications / Q000208:ethnology; D015850:Interleukin-6 / Q000097:blood; D024821:Metabolic Syndrome / Q000097:blood* / Q000150:complications / Q000208:ethnology; D008875:Middle Aged; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D015415:Biomarkers; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D005340:Fibrinogen; D002097:C-Reactive Protein